Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree, analyze the key aspect of trial data then start shopping the company, proven backers is the only way to stop this BS manipulation
Thoughts on timelines to secure a meeting with the FDA?
Wise man! I had better get in it!!!
So glad you created this account on the 16th of November, we would have been lost without your insights!
It would be great to start hearing more rumours of partnership or licensing to add fuel to the fire.
Please
Next piece of news: licensing or partnership?
Enjoy that which is most important, be well!
Hope you are doing well!
Thoughts on PR for tomorrow?
Do we get one first thing or at/after presentation time?
GLTA!
Good word play. Total sense indeed. Hopefully we will have enrolment ready to go as soon as possible and get these young girls the drug that could/will change their lives for the better soon. Maybe, it is just around the corner… wink!
Yes, we are. Thank you for the correction, I will listen again.
Pretty awesome, respectfully, I disagree. IMO, it seemed rushed, it deviated from historical after hours earnings calls which created undue excitement and anticipation which unfortunately resulted in disappointment when there was no news released. Some glaring other disappointments: no mentioned of PDD extension, as well as further delays for Excellence study. We had hope that study would have concluded in December, now we expect enrolment completion in December.
As Bill Belichick would say to avoid answering questions “we are on to Thursday and CTAD”
Great news is that I have a colonoscopy scheduled for tomorrow to help me pass the time until Thursday (sarc)
Exactly, WTF?
Our study must be much more comprehensive, right?!
Realistically, based on your knowledge and experience how long should it take to analyze the data of the 509 trial participants? I understand that it is an enormous amount of data that has been collected but honestly, 3 months should be enough time to analyze the top line, shouldn’t it?!
So if there are issues, what types of issues would you expect? What are the reasons why Anavex wouldn’t be presenting at CTAD? Is it just that the drug doesn’t work?
What are your thoughts on the theory that silence means that a partnership/licensing deal is on the horizon?
I really love the Quant Researcher hairstyles, specifically the last two. Bed head always equates to intelligence in my world!
I think that you are right, the 13th was my call.
If only our governments spent more time and energy on governing than just maintaining “power” and status.
Kudos to you and your ingenuity! Inspirational ideas, I think that some of us are realizing that self reliance and self sufficiency are extremely important in these times. From food security to energy
Great advice! Thank you.
We learned to manage through our cold Canadian winters but I am a wee bit worried for our European friends this winter.
I think being thankful for heat this Christmas maybe more appropriate than being disappointed about not having a new bicycle
Brutal, no wonder the markets don’t take this company seriously. I wonder how this plays into Dr. Misslings goal of maximizing shareholder value.
Do you know when that update occurred, T38?
She’d be a rich woman dumping 4 million shares in 2021 regardless of the dates of sale.
Sounds like my definition of “just around the corner”
Thanks for this, Investor, much appreciated! You and George make a great team.
Squid, I was worried, thank goodness you are back! I think his next presentation is at AAIC on July 31st
Good luck, Sab, hope all goes well!
Potential reaction to clinical trials site update? Perhaps, a reaction to no PR regarding AD trial completion?
It is a weird and dramatic move down.
In your opinion what does it mean to have hit and been repelled by the 13.40 resistance level 7 times? 8th time a charm?
I re-listened to the May 10th call today, around min17 TGD states that the PDD extension study was complete, could the data be analyzed and reviewed by now? I think you are right, the data could be ready for release at any point.
No, I’ve watched it. Multiple times but I still question the transparency and the lack of communication about timelines and information releases. You can’t tell me that the company is not sitting on data/information that is material to SP and company objectives. How is that for a double negative?!….
I am very optimistic about Anavex and I trust that TGD has a plan and a well thought out strategy but his communications leaves a lot to be desired. I find it insulting that the company still maintains excellence trial TLD by end of year. I hope that I am wrong about excellence TLD but if I held my breathe waiting for results I’d be long dead.
I can’t decide whether I love or hate the fact that Anavex doesn’t seem to give an F about retail investors.
Didn’t TGD once say that the trials were always designed to fail quickly, o have to believe at this stage they aren’t concerned about failure, perhaps more focused on the level of success? 9/10 is my score on that scale as well.
I think you may be right! Here is to
hoping!
I kinda feel as though I suffer from Stockholm syndrome
I have on Friday, LVM. No response yet
Perhaps in person attendees/or analysts were invited privately but the second Q PR states the R and D day is for shareholders and analysts.
I don’t recall, did anyone ask about the R and D day at the ASM? Was there a response?
Don’t worry, it is just around the corner. Brutal!